CIRM Quick Links
Related Links
Right Column
About CIRM
The California Institute for Regenerative Medicine ("The Institute" or "CIRM") was established in early 2005 with the passage of Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was approved by California voters on November 2, 2004, and called for the establishment of a new state agency to make grants and provide loans for stem cell research, research facilities and other vital research opportunities.
The Independent Citizens Oversight Committee ("ICOC") is the 29-member governing board for the Institute. The ICOC members are public officials, appointed on the basis of their experience earned in California's leading public universities, non-profit academic and research institutions, patient advocacy groups and the biotechnology industry.
What's New?
- Definition of California Supplier: Public Comment Solicitation 5/12/08
- California Stem Cell Agency, Donors and 12 California Institutions Commit $1.1 Billion to Increase the Capacity for Stem Cell Research in California 5/7/08
- RFA 08-02: CIRM Tools and Technologies Awards5/6/08
- Some Early Results from CIRM Grantees4/11/08
- CIRM Statement: CIRM Received 54 Applications for Second Round of New Faculty Grants4/8/08
- CIRM Statement: First Clinical Trial Begins for a Therapy Enabled By CIRM Funding 4/08/08
- CIRM Review Panel Makes Recommendations for Distribution Of $262 Million to Build Research Facilities in California 4/5/08
- REVIEW DRAFT: CIRM Guidelines for Reducing Risk in Oocyte Donation for Stem Cell Research 4/2/08